Feature | Stroke | Inga Shugalo
With its increasing role in medical imaging, artificial intelligence (AI) gradually is becoming a go-to technology for ...
May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in patients suffering from coronary artery disease using the company's new one-vial Oncardia (ethylenedicysteine-glucosamine) kits. The 60-patient trial study is being conducted in the U.S.
May 17, 2019
Feature | Information Technology | Carol Amick
According to the U.S. Department of Health and Human Services (HHS), about 70 percent of organizations are not compliant ...
May 17, 2019Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Technology | Antiplatelet and Anticoagulation Therapies
May 17, 2019 — The U.S. Food and Drug Administration (FDA) this week approved Fragmin (dalteparin sodium) injection, for ...
May 17, 2019
Technology | Analytics Software
Digital healthcare company Murj announced the availability of the Murj Analytics software-as-a-service (SaaS) platform for cardiac implantable electronic device (CIED) management. This new offering features powerful intelligence for cardiac device clinicians seeking to provide comprehensive population management through improved clinical, workforce and quality of care metrics.
May 17, 2019
At the 40th annual Heart Rhythm Scientific Sessions, May 8-11 in San Francisco, Acutus Medical announced the agreement to acquire Rhythm Xience Inc., and new strategic partnerships with Peerbridge Health, Cardiac Designs and MedFact. Acutus' expanded portfolio builds on the organization's mapping and visualization technology platform.
May 17, 2019Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News | ECG Monitoring Services
Preventice Solutions presented clinical data validating its BodyGuardian Remote Monitoring System with the BeatLogic deep learning platform at Heart Rhythm 2019, the Heart Rhythm Society’s 40th Annual Scientific Sessions, May 8-11 in San Francisco. This technology leverages machine learning and artificial intelligence (AI) for detection of atrial fibrillation (AF) and was validated using clinician adjudicated data.
May 16, 2019
Technology | Analytics Software
Johnson & Johnson Medical Devices Companies announced the launch of Biosense Webster Inc.’s Cartonet to help electrophysiologists, hospitals, health systems, and researchers leverage and share data, with the goal of improving patient outcomes and operational efficiency in catheter ablation procedures. Announced at Heart Rhythm 2019, the Heart Rhythm Society's (HRS) 40th Annual Heart Rhythm Scientific Sessions, May 8-11 in San Francisco, Cartonet is the world’s first cloud-based networking and data analytics software solution for the field of electrophysiology, according to the company.
May 16, 2019
News
Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter demonstrated safety and efficacy in achieving pulmonary vein isolation in patients with symptomatic drug-refractory paroxysmal atrial fibrillation (AF).
May 16, 2019Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Blog | HRS
The Heart Rhythm Society (HRS) 2019 Annual Scientific Sessions represent an important annual event for electrophysiology ...
May 16, 2019
News
CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3 System for the treatment of atrial fibrillation (AFib). The results, which demonstrated superior procedural times and impressive procedural outcomes, according to the company, were presented during the Heart Rhythm Society's (HRS) 40th Annual Scientific Sessions, May 8-11, 2019 in San Francisco.
May 16, 2019
Technology | Catheters
BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable introducer product family, designed for introducing various cardiovascular catheters into the heart, including via the left side of the heart through the interatrial septum.
May 16, 2019Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Videos | Cardiovascular Ultrasound
This is an example of how the heart's left atrial appendage (LAA) can be evaluated for thrombus and possible ...
May 16, 2019
Videos | Stroke
This is an example of a carotid artery reporting module from Change Healthcare at 2018 Radiological Society of North ...
May 16, 2019
Technology | Stent Grafts
W. L. Gore & Associates Inc. (Gore) announced the U.S. Food and Drug Administration (FDA) has granted regulatory approval for commercial distribution of the Gore Tag Conformable Thoracic Stent Graft with Active Control System. The device is a thoracic endovascular aortic repair (TEVAR) solution combining new levels of control with the performance of the Conformable Gore Tag Device. The device and delivery system provide new precision and predictable patient outcomes in the endovascular repair of aneurysms, transections and Type B dissections of the descending thoracic aorta. A smaller-diameter primary delivery sleeve gives the device and system a lower profile across 10 device sizes.
May 15, 2019© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now